spacer
home > epc
PUBLICATIONS

European Pharmaceutical Contractor

 

Published quarterly, European Pharmaceutical Contractor (EPC) covers the essential contract research issues between pharma companies and their CRO partners. The title, which is integrated within International Clinical Trials (ICT) magazine, offers a strategic view of the drug development industry giving its pharma, biotech and CRO readership expert insight and analysis on the sponsor-service provider landscape.

EPC focuses on key trends, concerns and developments in contract research operations across the drug development spectrum, from preclinical to post-marketing. It explores the shifting collaborative needs and practical implications for sponsors and their contract partners, with the emphasis on building and managing effective collaborations.

Prompted by the synergies between outsourcing and trial operations, EPC joined forces with sister brand ICT in late-2015, in a move that brings added value to both brands. With EPC now an inserted edition within ICT, industry practitioners across these complementary subject areas now have unrivalled access to a wealth of shared views and analyses.

 

For further information please contact:

Advertising
Craig Hannington 

Editorial
Niamh O'Brien

We're also on Twitter! Follow us @EPCmagazine

The latest digital edition of EPC can be viewed here
 

Read our publications on the go in the Samedan app for iPhone and iPad. You can download issues for offline reading and our archives go as far back as 2008! Download for free on the App Store.


epc
 
 
Featured in this issue
DATA MANAGEMENT
Electronic Data Interchange

Destination: Automation


A hands-off approach to trials, through to the automation of processes such as the managing of inventories, is a new industry goal, but Ian Davison at HMD Clinical suggests that this raises its own questions.
Supply Chain Management
Managing Risk

Risky Business


Nils Markmann at World Courier explains how manufacturers can prepare for growing challenges in the modern mobile supply chain, protecting both themselves and patients.
  Supply Chain Management
Local Trial Supply

The Hungarian Way


Many countries in the CEE region are now looking to local companies for several supply activities, so Tibor Kovacs at PharmaRoad expands on the reasons why Hungary is leading this trend.

spacer



Published quarterly in
February, May,
August and November


 

Industry Events

Cell & Gene Exchange 2017

22-23 May 2017, 1300 Pennsylvania Ave NW Washington, DC 20004

The Cell & Gene Exchange brings together leaders from patient advocacy groups, industry, academia and government to network, exchange ideas and explore partnership opportunities. This partnering conference will facilitate conversations among patient groups and key stakeholders to advancing potentially curative therapies for life-threatening diseases.
More info >>

 
News and Press Releases

MRC Technology monetises royalties on cancer drug Keytruda (pembrolizumab) to expand medical research activities, with a fund managed by DRI Capital


More info >>

air transport logo

 

White Papers

The Impact of Components on Drug Quality and Risk Mitigation

West Pharmaceutical Services, Inc.

Expectations for quality by regulatory agencies are increasing at a very fast pace, especially for prefilled drug delivery formats, thanks to increased focus on reducing risk to patient safety. The trend has resulted in delays for new drug applications, more recalls of marketed products and even drug shortages if the container system and drug contents are suspect for quality issues. The pharmaceutical market is now requiring manufacturers of containers and components to meet new expectations with a quality culture and very high product reliability. The need to bridge the gap and provide superior quality products has been a driver for manufacturing technology investments, more robust control strategies and the introduction of next generation elastomer components.
More info >>

©2000-2011 Samedan Ltd.
Add to favourites

Print this page

Send to a friend
Privacy statement